Navigation Links
Reprogram stem cells with heart tissue, which might improve treatments for heart disease

This release is available in Spanish.

Spanish researchers have employed for the first time adult cells extracted from a human heart to turn stem cells from adipose tissue into cardiac myocytes. In other words, they achieved to "reprogram" adult stem cells, which might improve treatments for heart disease therapeutical.

At present, the use of stem cells in treatments for heart disease is one of the most common practices. However, working with stem cells without targeting heart tissue negatively affects the efficacy of treatments. Therefore, inducing cell differentiation into cardiac muscle (cardiomyocytes) may be one of the best options in the treatment of these pathologies.

For the purpose of this study, researchers isolated adult human stem cells from lipoaspiration. Subsequently, these cells were temporarily permeabilized and exposed to a human-auricle cell extract. Then, these cells were recovered in culture.

Morphological Changes

After 21 days in culture, the cells differentiated towards a cardiac myocyte phenotype, which was demonstrated by expression of morphological changes (appearance of binuclear cells with striated fibers and ramifications), detection of cardiospecific markers through inmunofluorescence, and the presence of cardiac muscle-related genes that were analysed through RT-PCR; and finally, by expression of reverse transcription. Thus, mesenchimal stem cells acquired a cardiac phenotype.

This study was conducted by Macarena Pern, Juan A. Marchal, Elena Lpez, Manuel Jimnez-Navarro, Houria Boulaiz, Fernando Rodrguez-Serrano, Esmeralda Carrillo, Gema Snchez-Espn, Eduardo de Teresa, David Tosh y Antonia Arnega, researchers from the University of Jaen (Spain), the University of Granada, the Hospital Clnico Universitario of Malaga and the University of Bath (United Kingdom). It is going to be published on the Journal Cytotherapy, the official reporting organ of the International Society for Cellular Therapy (ISCT).

This technique could be used in the future for regeneration of cardiac muscles through the use of cells directly extracted from the patient. However, physicians have remarked that, at present, this research is in its earlier stages, and it will be a long time until it has any therapeutical use.

Currently, researchers are preparing a new approach for introducing the cell extract into the target cell (by using a cell microinjector) that will allow them to obtain a larger number of viable differentiated cells, which is essential for their having any therapeutical use. The following step is to use animal models to validate differentiated cells' functionality. Finally, a number of clinical trials should be conducted to assess the viability of this technique in human patients.


Contact: Antonia Aranega Jimenez
University of Granada

Related biology news :

1. March of Dimes awards $250,000 prize to scientist who discovered how to reprogram human cells
2. Fate Therapeutics announces creation of small molecule platform for commercial-scale reprogramming
3. Tumor suppressor pulls double shift as reprogramming watchdog
4. Reprogramming human cells without inserting genes
5. Study reveals a reprogrammed role for the androgen receptor
6. Study finds blood cells can be reprogrammed to act as embryonic stem cells
7. Researchers piggyback to safer reprogrammed stem cells
8. Reprogrammable cell type depends on a single gene to keep its identity
9. Salk researchers successfully reprogram keratinocytes attached to a single hair
10. Yamanaka eliminates viral vector in stem cell reprogramming
11. Salk researchers reprogram adult stem cells in their natural environment
Post Your Comments:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/10/2015)... Nov. 10, 2015  In this report, ... basis of product, type, application, disease indication, ... this report are consumables, services, software. The ... safety biomarkers, efficacy biomarkers, and validation biomarkers. ... are diagnostics development, drug discovery and development, ...
(Date:11/4/2015)... 2015 --> ... by Transparency Market Research "Home Security Solutions Market - Global ... - 2022", the global home security solutions market is expected to ... The market is estimated to expand at a CAGR ... 2022. Rising security needs among customers at homes, the ...
Breaking Biology News(10 mins):
(Date:11/30/2015)... ... November 30, 2015 , ... ... Manufacturing Practice (GMP) 10000 in the Santiago Marriott. The Global Stem Cells Group ... by a world-class team of qualified medical researchers and practitioners, experienced in administering ...
(Date:11/30/2015)... includes an MPP licen c ... , s Solid Drug Nanoparticle (SDN) Technology ; Aims ... through cost cuts of priority ... anywhere in the world will have the right to make, use and distribute lower ... licensees based anywhere in the world will have the right to make, use and ...
(Date:11/30/2015)... Md. , Nov. 30, 2015 ... development company committed to the fostering and monetization ... the current and prospective initiatives designed to create ... Chief Executive Officer of Spherix. "Based on published ... future licensees exceeds $50 billion and Spherix will ...
(Date:11/30/2015)... JACKSONVILLE, Florida , November 30, 2015 ... company specializing in the development of innovative peptide and ... & metastatic disease, today announced it will be presenting ... Event on December 1, 2015 at 2.30 PM PT. ... member and Strategic Advisor will be giving the presentation ...
Breaking Biology Technology: